Effect and Safety of Apatinib on Radiation-Induced Brain Injury
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
Purpose: This early phase 2 clinical trial aims to evaluate the therapeutic effects and
safety of apatinib in radiation-induced brain injury.
Further study details as provided by Sun Yet-sen Memorial Hospital, Sun Yat-sen University /
Yamei Tang.
Primary outcome measure: The proportion of patients with an objective response defined as ≥
25% reduction in brain edema volume on MR fluid attenuated inversion recovery (FLAIR) images.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University